Drug Trial Radar · NCT06931080
Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
630
Planned (sponsor's estimate)
Start
Apr 30, 2025
Primary completion
Dec 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Otsuka Pharmaceutical Co., Ltd.Otsuka
- Sponsor type
- Industry
- First posted
- Apr 16, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and examine the safety of two doses of EB-1020 QD XR capsule administered once daily orally in adult ADHD patients.
Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
EB-1020 (Centanafadine) 164.4 mgDrug
164.4 mg, capsule, oral, once daily, for 6 weeks
EB-1020 (Centanafadine) 328.8 mgDrug
328.8 mg, capsule, oral, once daily, for 6 weeks
PlaceboDrug
Placebo, capsule, oral, once daily, for 6 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in Adult ADHD Investigator Symptom Rating Scale (AISRS) score at Week6Time frame: Baseline, Weeks 6
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Maynds Tower Mental Clinic
Tokyo, Japan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.